Description: This is a discussion about new product developments, supplementary benefits - Accidental Death, Guaranteed Insurability and automatic inclusion of supplementary benefits rather than optional, product expense trends, considerations in setting commissions for policies with different characteristics, and analyzing and entering new markets.

Description: This discussion on annuities and settlement options focuses on: A. Revisions made recently in the interest and mortality bases for annuity contracts and retirement income policies and for settlement options embodied in life insurance policies. B. The extent to which the use of settlement options might be justified for payees other than the insured and beneficiaries who are natural persons. C. The practical problems arising in connection with: 1 Requests for elaborate or complicated settlements 2 Liberal settlement option guarantees in outstanding policies

Description: Discusses the extent to which various influences are reflected in premiums, dividends and settlement options: improved mortality, interest rate trends, federal taxes, agent compensation and increasing expenses.

Description: This general discussion looks at problems or solutions developed in the field of agents' compensation, considerations leading companies to recent reductions in individual annuity rates, trend to offer first year cash values, increasing demand for the issuance of insurance at ages up to 70 and beyond, and if the SOA should give consideration to elective subjects in the Fellowship exam.

Description: A. Discusssion of the practical considerations involved in deciding whether or not to adopt projected mortality rates in connection with individual annuities, settlement options, retirement income policies, and the various forms of group annuities. B. In view of increased administrative expenses, discussion of the arguments for and against imposing limitations on the granting of settlement options with respect to size of policy, including the practicality of providing for the expense of administering supplementary contracts other than through the use of conservative mortality and interest assumptions.